Publications
Publications 7676 - 7700 de 33557
| Titre | DOI |
|---|---|
|
Cytochrome P450-Dependent Metabolism of Caffeine in Drosophila melanogaster A. Coelho; S. Fraichard; G. Le Goff; P. Faure; Y. Artur; J.F. Ferveur; J.M. Heydel 2015 |
10.1371/journal.pone.0117328 |
|
CYTOGENETICS AND LONG-TERM SURVIVAL IN MM-003, A PHASE 3 TRIAL OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA M.A. Dimopoulos; K. Weisel; K.W. Song; M. Delforge; L. Karlin; H. Goldschmidt; P. Moreau; A. Banos; A. Oriol; L. Garderet; M. Cavo; V. Ivanova; A. Alegre; J. Martinez-Lopez; C.I. Chen; A. Spencer; S. Knop; N.J. Bahlis; C. Renner; X. Yu; K. Hong; L. Sternas; C. Jacques; M.H. Zaki; J.F. San Miguel 2014 |
|
|
Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone M.A. Dimopoulos; K.C. Weisel; K.W. Song; M. Delforge; L. Karlin; H. Goldschmidt; P. Moreau; A. Banos; A. Oriol; L. Garderet; M. Cavo; V. Ivanova; A. Alegre; J. Martinez-Lopez; C. Chen; A. Spencer; S. Knop; N.J. Bahlis; C. Renner; X. Yu; K. Hong; L. Sternas; C. Jacques; M.H. Zaki; J.F. San Miguel 2015 |
10.3324/haematol.2014.117077 |
|
Cytogenetics in the management of lymphomas and lymphoproliferative disorders in adults and children: an update by the Groupe francophone de cytogenetique hematologique (GFCH) C. Lefebvre; E. Callet-Bauchu; E. Chapiro; N. Nadal; D. Penther; H. Antoine-Poirel 2016 |
10.1684/abc.2016.1179 |
|
Cytokine and eicosanoid profiles of phosphate mine workers M. Khelifi; A. Zarrouk; T. Nury; H. Hamed; S. Saguem; R. Ben Salah; J.M. Riedinger; G. Lizard 2014 |
10.2131/jts.39.465 |
|
Cytokine Signature in Schnitzler Syndrome: Proinflammatory Cytokine Production Associated to Th Suppression M.Masson Regnault; E. Frouin; I. Jeru; A. Delwail; S. Charreau; S. Barbarot; A. Neel; A. Masseau; X. Puechal; X. Kyndt; S. Gayet; F. Lifermann; B. Asli; X. Balguerie; C. Blanchard-Delaunay; F. Aubin; R. Rizzi; F. Rongioletti; T. Boye; L. Gusdorf; D. Bessis; F. Morel; E. Hainaut; D. Lipsker; J.C. Lecron 2020 |
10.3389/fimmu.2020.588322 |
|
Cytomics and morphometry of tobacco cells expressing the C-terminal domain of the clathrin heavy chain C. Eicher; C. Der; C. Conreux; J. Fromentin; N. Leborgne-Castel; S. Ochatt 2018 |
|
|
Cytomics and morphometry of tobacco cells expressing the C-terminal domain of the clathrin heavy chain C. Eicher; C. Der; C. Conreux; J. Fromentin; N. Leborgne-Castel; S. Ochatt 2018 |
|
|
Cytoplasmic and Nuclear Functions of cIAP1 A. Zadoroznyj; L. Dubrez 2022 |
10.3390/biom12020322 |
|
Cytoprotective Activities of Milk Thistle Seed Oil Used in Traditional Tunisian Medicine on 7-Ketocholesterol and 24S-Hydroxycholesterol-Induced Toxicity on 158N Murine Oligodendrocytes W. Meddeb; L. Rezig; A. Zarrouk; T. Nury; A. Vejux; M. Prost; L. Bretillon; M. Mejri; G. Lizard 2018 |
10.3390/antiox7070095 |
|
Cytoprotective and antioxidant properties of organic selenides for the myelin-forming cells, oligodendrocytes S. Shaaban; D. Vervandier-Fasseur; P. Andreoletti; A. Zarrouk; P. Richard; A. Negm; G. Manolikakes; C. Jacob; M. Cherkaoui-Malki 2018 |
10.1016/j.bioorg.2018.05.019 |
|
Cytoprotective and Neurotrophic Effects of Octadecaneuropeptide (ODN) in in vitro and in vivo Models of Neurodegenerative Diseases O. Masmoudi-Kouki; A. Namsi; Y. Hamdi; S. Bahdoudi; I. Ghouili; J. Chuquet; J. Leprince; B. Lefranc; T. Ghrairi; M.C. Tonon; G. Lizard; D. Vaudry 2020 |
10.3389/fendo.2020.566026 |
|
Cytoprotective Effects of Natural Highly Bio-Available Vegetable Derivatives on Human-Derived Retinal Cells I. Munia; L. Gafray; M.A. Bringer; P. Goldschmidt; L. Proukhnitzky; N. Jacquemot; C. Cercy; K.Ramchani Ben Otman; M.Helene Errera; I. Ranchon-Cole 2020 |
10.3390/nu12030879 |
|
Cytoprotective organoselenium compounds for oligodendrocytes S. Shaaban; A. Zarrouk; D. Vervandier-Fasseur; Y.S. Al-Faiyz; H. El-Sawy; I. Althagafi; P. Andreoletti; M. Cherkaoui-Malki 2021 |
10.1016/j.arabjc.2021.103051 |
|
Cytoreduction nephrectomy: No future? L. Balssa; F. Kleinclauss; H. Almotlak; A. Thiery-Vuillemin 2018 |
10.1016/j.bulcan.2018.08.009 |
|
Cytoreductive nephrectomy (CN) in metastatic renal cancer (mRCC): Update on Carmena trial with focus on intermediate IMDC-risk population. A. Mejean; S. Thezenas; C. Chevreau; K. Bensalah; L. Geoffrois; A. Thiery-Vuillemin; L. Cormier; H. Lang; L. Guy; G. Gravis; F. Rolland; C. Linassier; M.O. Timsit; L. Albiges; S. Oudard; T. Lebret; J.M. Treluyer; S. Colas; B. Escudier; A. Ravaud 2019 |
10.1200/JCO.2019.37.15_suppl.4508 |
|
Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups I. Amblard; F. Mercier; D.L. Bartlett; S.A. Ahrendt; K.W. Lee; H.J. Zeh; E.A. Levine; D. Baratti; M. Deraco; P. Piso; D.L. Morris; B. Rau; A.A.K. Tentes; J.J. Tuech; F. Quenet; E. Akaishi; M. Pocard; Y. Yonemura; G. Lorimier; D. Delroeux; L. Villeneuve; O. Glehen; G. Passot; P.S.O.G.I.Working Grp; B.I.G.R.E.N.A.P.E.Wor Grp 2018 |
10.1016/j.ejso.2018.04.023 |
|
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis in the Elderly: A Case-Controlled, Multicenter Study M. Alyami; P. Lundberg; V. Kepenekian; D. Goere; J.M. Bereder; S. Msika; G. Lorimier; F. Quenet; G. Ferron; E. Thibaudeau; K. Abboud; R.Lo Dico; D. Delroeux; C. Brigand; C. Arvieux; F. Marchal; J.J. Tuech; J.M. Guilloit; F. Guyon; P. Peyrat; D. Pezet; P. Ortega-Deballon; F. Zinzindohoue; C. De Chaisemartin; R. Kianmanesh; O. Glehen; G. Passot; B.I.G.R.E.N.A.P.E.Working Grp; R.E.N.A.P.E.Working Grp 2016 |
10.1245/s10434-016-5519-2 |
|
Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors T. Charrier; G. Passot; J. Peron; C. Maurice; S. Gocevska; F. Quenet; C. Eveno; M. Pocard; D. Goere; D. Elias; P. Ortega-Deballon; D. Vaudoyer; E. Cotte; O. Glehen 2016 |
10.1245/s10434-016-5143-1 |
|
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial F. Quenet; D. Elias; L. Roca; D. Goere; L. Ghouti; M. Pocard; O. Facy; C. Arvieux; G. Lorimier; D. Pezet; F. Marchal; V. Loi; P. Meeus; B. Juzyna; H. de Forges; J. Paineau; O. Glehen; U.N.I.C.A.N.C.E.R.G.I. Grp; B.I.G.Renape Grp 2021 |
10.1016/S1470-2045(20)30599-4 |
|
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis P.E. Bonnot; G. Piessen; V. Kepenekian; E. Decullier; M. Pocard; B. Meunier; J.M. Bereder; K. Abboud; F. Marchal; F. Quenet; D. Goere; S. Msika; C. Arvieux; N. Pirro; R. Wernert; P. Rat; J. Gagniere; J.H. Lefevre; T. Courvoisier; R. Kianmanesh; D. Vaudoyer; M. Rivoire; P. Meeus; G. Passot; O. Glehen; J. Abba; M. Alyami; N. Bakrin; J.L. Bernard; F. Bibeau; D. Bouzard; C. Brigand; S. Carrere; M. Carretier; B. Castel; E. Cotte; B. Celerier; C. Ceribelli; C. De Chaisemartin; V. De Franco; S. Deguelte-Lardiere; R. Debre; J.R. Delpero; G. Desolneux; F. Dumont; C. Eveno; S. Durand-Fontanier; S. Evrard; O. Facy; F.N. Gilly; P. Gourdiole; J.M. Guilloit; B. Heyd; B. Lelong; R.Lo Dico; V. Loi; P. Mariani; J.L. Meffert; P. Ortega-Deballon; B. Paquette; C. Petorin; P. Peyrat; D. Pezet; J.M. Regimbeau; S. Rohr; C. Sabbagh; J.F. Seitz; O. Sgarbura; I. Sielezneff; I. Sourrouille; A. Taibi; E. Thibaudeau; J.J. Tuech; J. Vanbockstael; F. Zinzindohoue; F.R.E.G.A.T. Network; B.I.G.R.E.N.A.P.E. Network 2019 |
10.1200/JCO.18.01688 |
|
Cytotect (R) CP as salvage therapy in patients with CMV infection following allogeneic hematopoietic cell transplantation: a multicenter retrospective study T. Alsuliman; C. Kitel; R. Dulery; T. Guillaume; F. Larosa; J. Cornillon; H. Labussiere-Wallet; C. Mediavilla; S. Belaiche; J. Delage; S. Alain; I. Yakoub-Agha 2018 |
10.1038/s41409-018-0166-9 |
|
Cytotoxic effects of chemotherapy on cancer and immune cells: how can it be modulated to generate novel therapeutic strategies? C. Rebe; F. Ghiringhelli 2015 |
10.2217/fon.15.198 |
|
Cytotoxic glycosides from the roots of Weigela x ``Bristol Ruby'' D.Hung Nguyen; A.C. Mitaine-Offer; S. Maroso; A.M. Papini; T. Paululat; P.S. Bellaye; B. Collin; O. Chambin; M.A. Lacaille-Dubois 2019 |
10.1016/j.fitote.2019.104242 |
|
Cytotoxic steroidal glycosides from Allium flavum A. Rezgui; A.C. Mitaine-Offer; T. Paululat; S. Delemasure; P. Dutartre; M.A. Lacaille-Dubois 2014 |
10.1016/j.fitote.2013.12.018 |